Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
ACCE to “close the care gap” via clinical trials, cancer screenings and patient navigation services. Plus: A congressional resolution.
The program supports American Indian/Alaska Native people, who experience the highest rates of hepatitis C virus infection.
Almost everyone who completed treatment was cured, but about 40% of those diagnosed with HCV never started antiviral therapy.
Here’s how the funding will reach American Indians and Alaska Natives, who see higher rates of HIV, hepatitis C and STIs.
Certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed.
Among Native Americans, the COVID-19 vaccine rollout so far has been a success story.
But American Indians and Alaska Natives saw the sharpest increase in deaths involving methamphetamines. Here’s a possible solution.
More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.
Alaska has eliminated new HAV and HBV infections and linked 90% of patients with chronic HBV to care in the Alaska Native population.
Such a collaboration successfully provided treatment to a population of Native Americans and Alaska Natives.
Inhabitants are facing mounting hepatitis A, addiction and overdose risks.
Disparities in access to health care make Native Americans, Aboriginals and others up to 10 times more likely to be infected.
Recent hepatitis C data shows the American Indian and Alaska Native population had the highest rate of new infections of all ethnic groups.
So far, nearly 23,000 people have been screened for viral liver disease under the tribe’s ambitious health initiative.
They are the first community in the United States to set this goal
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.